Outcomes among Pregnant Women with Measles and Their Infants in the United States — Preliminary Analysis, 2025–2026
NEJM Evidence · 16.11.2026
DOI: 10.1056/evidpha2600416 ↗Kurz gefasst
Fachartikel in der Zeitschrift NEJM Evidence, online erschienen am 16.11.2026. Verfasst von Elizabeth L Lewis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prev…. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
AbstractMeasles virus infection during pregnancy can result in severe maternal illness, adverse pregnancy and infant outcomes, and neonatal complications, including congenital measles. During multiple large outbreaks from January 1, 2025, to September 28, 2026, a total of 112 cases of confirmed measles during pregnancy and 13 cases of congenital measles were reported to the Centers for Disease Control and Prevention; complications included maternal pneumonia, preterm delivery, and neonatal complications. Almost all pregnant women with measles (98%) had not received measles-mumps-rubella (MMR) vaccination before pregnancy or had unknown vaccination status. MMR vaccination before pregnancy and high community MMR vaccination coverage are important to prevent measles and related complications.
Autor:innen und Institutionen
- Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- ASRT, Smyrna, GA, USA.
- CDC Foundation, Atlanta, GA, USA.
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Zitieren
APA
Lewis, E. L., Chang, D., Wiley, N., Roth, N. M., Ezekwe, C., Park, L. A., Tong, V. T., DeSisto, C. L., Lee, L., Link-Gelles, R., & Filardo, T. D. (2026). Outcomes among Pregnant Women with Measles and Their Infants in the United States — Preliminary Analysis, 2025–2026. NEJM Evidence. https://doi.org/10.1056/evidpha2600416
Vancouver
Lewis EL, Chang D, Wiley N, Roth NM, Ezekwe C, Park LA, et al. Outcomes among Pregnant Women with Measles and Their Infants in the United States — Preliminary Analysis, 2025–2026. NEJM Evidence. 2026. doi:10.1056/evidpha2600416
BibTeX
@article{Lewis2026,
author = {Lewis, Elizabeth L and Chang, Daniel and Wiley, Nicole and Roth, Nicole M and Ezekwe, Chinyere and Park, Lois A and Tong, Van T and DeSisto, Carla L and Lee, Lily and Link-Gelles, Ruth and Filardo, Thomas D},
title = {Outcomes among Pregnant Women with Measles and Their Infants in the United States — Preliminary Analysis, 2025–2026},
journal = {NEJM Evidence},
year = {2026},
doi = {10.1056/evidpha2600416}
}
EUVIMED